<DOC>
	<DOCNO>NCT02331394</DOCNO>
	<brief_summary>The current proposal feasibility acceptability study establish necessary groundwork detailed investigation role CH reduce symptom improve quality life NSCLC patient Jewish General Hospital ( JGH ) . A standardized easily administer form CH use , incorporate carefully select combination herb design alleviate range common symptom suffer patient advanced NSCLC .</brief_summary>
	<brief_title>A Feasibility Study Chinese Herbs Manage Cancer-related Symptoms Patients With Advanced NSCLC</brief_title>
	<detailed_description>Patients advance NSCLC , addition poor chance cure extend survival , frequently suffer range different symptom related disease treatment . As result press need develop effective anti-cancer therapy imperative enhance effect exist treatment alleviate symptom effectively . Increasing number patient cancer use complementary medicine , include Chinese herb ( CH ) , evidence accumulate grow number laboratory study clinical trial , CH may exert beneficial effect cancer patient many way . The current proposal feasibility acceptability study establish necessary groundwork detailed investigation role CH reduce symptom improve quality life NSCLC patient JGH . A standardized easily administer form CH use , incorporate carefully select combination herb design alleviate range common symptom suffer patient advanced NSCLC . This prospective , longitudinal cohort study 6-week clinical intervention Chinese herb advance ( Stage 4 ) NSCLC patient All active patient histologically cytologically proven metastatic NSCLC Eastern Cooperative Oncology Group ( ECOG ) performance status 0 -2 eligible participate study . Quality life assess FACT-L Edmonton Symptom Assessment System ( ESAS ) questionnaires . Patient instruct complete diary day confirm adherence treatment indicate reason ( ) dose missed treatment stop .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Stages 4 ECOG performance ≤ 3 Life expectancy great ≥ 3 month Receiving Tyrosine Kinase Inhibitors ( TKI ) , ( Tarceva , Iressa ) Brain metastases Patients family speak English French Abnormal liver function : Alanine aminotransaminase ( ALT ) &gt; 40 U/L , Aspartate aminotransaminase ( AST ) &gt; 55 U/L , Alkaline phosphatase ( ALP ) &gt; 145 U/L , Bilirubin &gt; 1.7 umol/L . Taking regular anticonvulsant , Coumadin relate anticoagulant , lithium Taking regular immunosuppressive medication : azathioprine ( Imuran ) , basiliximab ( Simulect ) , cyclosporine ( Neoral , Sandimmune ) , daclizumab ( Zenapax ) , muromonabCD3 ( OKT3 , Orthoclone OKT3 ) , mycophenolate ( CellCept ) , tacrolimus ( FK506 , Prograf ) , sirolimus ( Rapamune )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Chinese herb</keyword>
	<keyword>lung cancer</keyword>
	<keyword>quality life</keyword>
</DOC>